ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth

• Alpha 6.03%
• Beta 0.94
• Sharpe Ratio1.25
• Std Deviation 15.85%
• Tracking Error 5.21%

To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.

The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth has an AUM of 6801.16 crores & has delivered CAGR of 17.00% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 1.86%. The minimum investment in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth is Rs 5000 and the minimum SIP is Rs 100.

As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.

The top holdings of the fund include Sun Pharmaceutical Industries, Cipla, Mankind Pharma & Dr Reddy's Laboratories.

The major sectors where the fund is invested are Biotechnology & Drugs, Major Drugs, Healthcare Facilities & Retail (Drugs).

Some of the similar funds are ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth, SBI Healthcare Opportunities Fund Regular Growth, Mirae Asset Healthcare Fund Regular Growth, Nippon India Pharma Fund - Growth, DSP Healthcare Fund Regular Growth. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth has a sharpe ratio of 1.25 & a standard deviation of 15.85%.